Weiduo Hou

502 total citations
15 papers, 371 citations indexed

About

Weiduo Hou is a scholar working on Molecular Biology, Oncology and Materials Chemistry. According to data from OpenAlex, Weiduo Hou has authored 15 papers receiving a total of 371 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 6 papers in Oncology and 3 papers in Materials Chemistry. Recurrent topics in Weiduo Hou's work include Bone Metabolism and Diseases (8 papers), Bone health and treatments (5 papers) and Advanced Nanomaterials in Catalysis (3 papers). Weiduo Hou is often cited by papers focused on Bone Metabolism and Diseases (8 papers), Bone health and treatments (5 papers) and Advanced Nanomaterials in Catalysis (3 papers). Weiduo Hou collaborates with scholars based in China and Japan. Weiduo Hou's co-authors include Chenyi Ye, Mo Chen, Rongxin He, Erman Chen, Jinwei Lu, Lan Tang, Weixu Li, Wei Gao, Jianrong Wu and Xiaojun Cai and has published in prestigious journals such as Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, Journal of Orthopaedic Research® and Cell Death and Disease.

In The Last Decade

Weiduo Hou

14 papers receiving 368 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Weiduo Hou China	10	187	98	86	64	50	15	371
Xiankun Cao China	15	254 1.4×	181 1.8×	107 1.2×	72 1.1×	75 1.5×	32	666
Dongye Yang China	7	199 1.1×	80 0.8×	29 0.3×	58 0.9×	17 0.3×	18	417
Wenjin Xiao China	13	189 1.0×	152 1.6×	31 0.4×	66 1.0×	47 0.9×	38	501
Guowei Shang China	12	205 1.1×	66 0.7×	35 0.4×	22 0.3×	62 1.2×	24	415
Zeyuan Zhong China	12	262 1.4×	87 0.9×	33 0.4×	51 0.8×	21 0.4×	23	495
Yanran Huang China	13	193 1.0×	106 1.1×	19 0.2×	42 0.7×	95 1.9×	37	468
Sheng Lü China	16	324 1.7×	178 1.8×	74 0.9×	115 1.8×	45 0.9×	36	685
Hongsheng Zhan China	13	163 0.9×	74 0.8×	107 1.2×	44 0.7×	121 2.4×	90	649
Zixiang Wu China	10	291 1.6×	55 0.6×	21 0.2×	73 1.1×	26 0.5×	18	490
Chenhui Cai China	5	140 0.7×	87 0.9×	23 0.3×	34 0.5×	112 2.2×	11	369

Countries citing papers authored by Weiduo Hou

Since Specialization

Citations

This map shows the geographic impact of Weiduo Hou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weiduo Hou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weiduo Hou more than expected).

Fields of papers citing papers by Weiduo Hou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weiduo Hou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weiduo Hou. The network helps show where Weiduo Hou may publish in the future.

Co-authorship network of co-authors of Weiduo Hou

This figure shows the co-authorship network connecting the top 25 collaborators of Weiduo Hou. A scholar is included among the top collaborators of Weiduo Hou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weiduo Hou. Weiduo Hou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Zhang, Wei, Xiaowen Jiang, Weiduo Hou, et al.. (2025). Conditional deletion of Pink1 in mesenchymal stem cells suppresses osteogenesis through downregulation of Apoh transcription. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1871(4). 167739–167739.

Chen, Erman, et al.. (2023). Finite element analysis of sacral‐alar‐iliac screw fixation for sacroiliac joint dislocation. Journal of Orthopaedic Research®. 41(8). 1821–1830. 3 indexed citations

Zhang, Wei, Xingzhi Zhou, Weiduo Hou, et al.. (2022). Reversing the imbalance in bone homeostasis via sustained release of SIRT-1 agonist to promote bone healing under osteoporotic condition. Bioactive Materials. 19. 429–443. 36 indexed citations

Hou, Weiduo, Mo Chen, Chenyi Ye, et al.. (2022). Parkin Inhibits RANKL-Induced Osteoclastogenesis and Ovariectomy-Induced Bone Loss. Biomolecules. 12(11). 1602–1602. 4 indexed citations

Ye, Chenyi, Wei Zhang, Kai Zhang, et al.. (2022). Prussian Blue Nanozyme Normalizes Microenvironment to Delay Osteoporosis. Advanced Healthcare Materials. 11(19). e2200787–e2200787. 37 indexed citations

Ye, Chenyi, Wei Zhang, Kai Zhang, et al.. (2022). Prussian Blue Nanozyme Normalizes Microenvironment to Delay Osteoporosis (Adv. Healthcare Mater. 19/2022). Advanced Healthcare Materials. 11(19). 2 indexed citations

Hou, Weiduo, Chenyi Ye, Mo Chen, et al.. (2021). Excavating bioactivities of nanozyme to remodel microenvironment for protecting chondrocytes and delaying osteoarthritis. Bioactive Materials. 6(8). 2439–2451. 86 indexed citations

Lu, Jinwei, Zhihui Kuang, Tao Chen, et al.. (2020). Isoalantolactone inhibits RANKL-induced osteoclast formation via multiple signaling pathways. International Immunopharmacology. 84. 106550–106550. 12 indexed citations

Zhang, Wei, Weiduo Hou, Mo Chen, et al.. (2020). Upregulation of Parkin Accelerates Osteoblastic Differentiation of Bone Marrow-Derived Mesenchymal Stem Cells and Bone Regeneration by Enhancing Autophagy and β-Catenin Signaling. Frontiers in Cell and Developmental Biology. 8. 576104–576104. 16 indexed citations

10.

Lu, Jinwei, Chenyi Ye, Yanyong Huang, et al.. (2020). Corilagin suppresses RANKL‐induced osteoclastogenesis and inhibits oestrogen deficiency‐induced bone loss via the NF‐κB and PI3K/AKT signalling pathways. Journal of Cellular and Molecular Medicine. 24(18). 10444–10457. 18 indexed citations

11.

Hou, Weiduo, Chenyi Ye, Mo Chen, et al.. (2019). Bergenin Activates SIRT1 as a Novel Therapeutic Agent for Osteogenesis of Bone Mesenchymal Stem Cells. Frontiers in Pharmacology. 10. 618–618. 19 indexed citations

12.

Ye, Chenyi, Wei Zhang, Kai Hang, et al.. (2019). Extracellular IL-37 promotes osteogenic differentiation of human bone marrow mesenchymal stem cells via activation of the PI3K/AKT signaling pathway. Cell Death and Disease. 10(10). 753–753. 69 indexed citations

13.

Ye, Chenyi, Weiduo Hou, Mo Chen, et al.. (2019). IGFBP7 acts as a negative regulator of RANKL‐induced osteoclastogenesis and oestrogen deficiency‐induced bone loss. Cell Proliferation. 53(2). e12752–e12752. 34 indexed citations

14.

Ye, Chenyi, Mo Chen, Erman Chen, et al.. (2018). Knockdown of FOXA2 enhances the osteogenic differentiation of bone marrow-derived mesenchymal stem cells partly via activation of the ERK signalling pathway. Cell Death and Disease. 9(8). 836–836. 32 indexed citations

15.

Hou, Weiduo, Chenyi Ye, Weixu Li, et al.. (2018). Bioengineering application using co-cultured mesenchymal stem cells and preosteoclasts may effectively accelerate fracture healing. Medical Hypotheses. 123. 24–26. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact